Cyra Leurs

Cyra Leurs

UNVERIFIED PROFILE

Are you Cyra Leurs?   Register this Author

Register author
Cyra Leurs

Cyra Leurs

Publications by authors named "Cyra Leurs"

Are you Cyra Leurs?   Register this Author

11Publications

-Reads

The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing.

Mult Scler 2018 May 9;24(6):805-810. Epub 2017 May 9.

Department of Neurology, Amsterdam Neuroscience, VUmc MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.

View Article
May 2018

Cerebrospinal fluid mtDNA concentration is elevated in multiple sclerosis disease and responds to treatment.

Mult Scler 2018 Apr 15;24(4):472-480. Epub 2017 Mar 15.

Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.

View Article
April 2018

Disease activity following pregnancy-related discontinuation of natalizumab in MS.

Neurol Neuroimmunol Neuroinflamm 2018 Jan 5;5(1):e424. Epub 2017 Dec 5.

Department of Neurology (I.K., Z.L.E.v.K., C.E.L., I.D., C.E.P.v.M., B.A.d.J., B.W.v.O., B.M.J.U., J.K.), Amsterdam Neuroscience, VUmc MS Center Amsterdam, VU University Medical Center; Department of Immunology (T.R.), Landsteiner Laboratory Sanquin Research, Amsterdam; Department of Epidemiology and Biostatistics (B.I.L.-W.), VU University Medical Center; and Department of Radiology & Nuclear Medicine (I.D., M.P.W.), VUmc MS Center, Amsterdam, The Netherlands.

View Article
January 2018

Five cases of malignant melanoma during fingolimod treatment in Dutch patients with MS.

Neurology 2017 Aug 2;89(9):970-972. Epub 2017 Aug 2.

From the Department of Neurology, Amsterdam Neuroscience, VUmc MS Centre Amsterdam (J.K., C.E.L., B.M.J.U.) and Department of Medical Oncology (A.J.M.v.d.E.), VU University Medical Centre; Department of Neurology (E.L.J.H.), St. Antonius Hospital Utrecht; Department of Neurology (J.v.E.), Jeroen Bosch Hospital, 's-Hertogenbosch; and Department of Neurology (J.P.M.), Rijnstate Hospital, Arnhem, the Netherlands.

View Article
August 2017

Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets.

Cancer Cell 2017 08;32(2):238-252.e9

Department of Neurosurgery, VU University Medical Center, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Brain Tumor Center Amsterdam, VU University Medical Center, Cancer Center Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Department of Neurology, Massachusetts General Hospital and Neuroscience Program, Harvard Medical School, 149 13(th) Street, Charlestown, MA 02129, USA. Electronic address:

View Article
August 2017

Switching natalizumab to fingolimod within 6 weeks reduces recurrence of disease activity in MS patients.

Mult Scler 2017 Aug 1:1352458517726381. Epub 2017 Aug 1.

Department of Neurology, Neuroscience Amsterdam, VUmc MS Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.

View Article
August 2017

Natalizumab-associated progressive multifocal leukoencephalopathy is not preceded by elevated drug concentrations.

Mult Scler 2017 Jun 13;23(7):995-999. Epub 2016 Dec 13.

Department of Neurology, Neuroscience Campus Amsterdam, VUmc MS Center Amsterdam, VU University Medical Center Amsterdam, Amsterdam, The Netherlands.

View Article
June 2017

Body fluid biomarkers for multiple sclerosis--the long road to clinical application.

Nat Rev Neurol 2015 Oct 22;11(10):585-96. Epub 2015 Sep 22.

Department of Neurology, Neuroscience Campus Amsterdam, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, Netherlands.

View Article
October 2015